An open-label prospective study of Depakote for behavioral and psychological symptoms in dementia (BPSD): use alone and in co-prescription with atypical antipsychotic medications

Trial Profile

An open-label prospective study of Depakote for behavioral and psychological symptoms in dementia (BPSD): use alone and in co-prescription with atypical antipsychotic medications

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Valproate semisodium (Primary)
  • Indications Dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top